Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P39060 (
endostatin
)
2,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Specific internalization of
endostatin
into endothelial cells has been proved to be important for its biologic functions. However, the mechanism of
endostatin
internalization still remains elusive. In this study, we report for the first time that both caveolae/lipid rafts and clathrin-coated pits are involved in
endostatin
internalization. Inhibition of either the caveolae pathway or the clathrin pathway with the use of chemical inhibitors, small interfering RNAs, or dominant-negative mutants alters
endostatin
internalization in vitro. Intriguingly, cholesterol sequestration by nystatin, a polyene antifungal drug, significantly enhances
endostatin
uptake by endothelial cells through switching
endostatin
internalization predominantly to the clathrin-mediated pathway.
Nystatin
-enhanced internalization of
endostatin
also increases its inhibitory effects on endothelial cell tube formation and migration. More importantly, combined treatment with nystatin and
endostatin
selectively enhances
endostatin
uptake and biodistribution in tumor blood vessels and tumor tissues but not in normal tissues of tumor-bearing mice, ultimately resulting in elevated antiangiogenic and antitumor efficacies of
endostatin
in vivo. Taken together, our data show a novel mechanism of
endostatin
internalization and support the potential application of enhancing the uptake and therapeutic efficacy of
endostatin
via regulating distinct endocytic pathways with cholesterol-sequestering agents.
...
PMID:Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. 2148 7